← 產業報告目錄
Colloids (Blood Plasma) Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-08頁數 145報告編號 APO-a87b0d56b6
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.
The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.
Report Scope
This report quantifies the global Colloids (Blood Plasma) market in terms of revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Colloids (Blood Plasma) Market by Company
CSL Behring
Baxter
Grifols
Octapharma
Kedrion
Shanghai Raas
CTBB
Hualan Bio
Rongsheng Pharmaceutical
Boya Rongsheng
B. Braun Medical
Fresenius Kabi
HOSPIRA
Axa parenterals
Fresenius Kabi (China)
CR Double-Crane
Kelun Group
Shandong Qidu Pharmaceutical
Shandong Hualu Pharmaceutical
Minsheng Pharma
Kanglepharm
Colloids (Blood Plasma) Segment by Type
Natural Type Colloids (Blood Plasma)
Synthetic Type Colloids (Blood Plasma)
Colloids (Blood Plasma) Segment by Application
Extensive Burns
Massive Blood or Plasma Loss
Hypovolemic Shock
Others
Colloids (Blood Plasma) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colloids (Blood Plasma) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Colloids (Blood Plasma) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colloids (Blood Plasma).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Colloids (Blood Plasma) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Colloids (Blood Plasma) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Colloids (Blood Plasma) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Colloids (Blood Plasma) Market Size (2021-2032)
2.2.2 Global Colloids (Blood Plasma) Sales (2021-2032)
2.2.3 Global Colloids (Blood Plasma) Market Average Price (2021-2032)
2.3 Colloids (Blood Plasma) by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Natural Type Colloids (Blood Plasma)
2.3.3 Synthetic Type Colloids (Blood Plasma)
2.4 Colloids (Blood Plasma) by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Extensive Burns
2.4.3 Massive Blood or Plasma Loss
2.4.4 Hypovolemic Shock
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Colloids (Blood Plasma) Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Colloids (Blood Plasma) Sales (MT) of Manufacturers (2021-2026)
3.3 Global Colloids (Blood Plasma) Revenue of Manufacturers (2021-2026)
3.4 Global Colloids (Blood Plasma) Average Price by Manufacturers (2021-2026)
3.5 Global Colloids (Blood Plasma) Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Colloids (Blood Plasma), Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Colloids (Blood Plasma), Product Type & Application
3.8 Global Manufacturers of Colloids (Blood Plasma), Established Date
3.9 Global Colloids (Blood Plasma) Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 CSL Behring
4.1.1 CSL Behring Company Information
4.1.2 CSL Behring Business Overview
4.1.3 CSL Behring Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.1.4 CSL Behring Colloids (Blood Plasma) Product Portfolio
4.1.5 CSL Behring Recent Developments
4.2 Baxter
4.2.1 Baxter Company Information
4.2.2 Baxter Business Overview
4.2.3 Baxter Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Baxter Colloids (Blood Plasma) Product Portfolio
4.2.5 Baxter Recent Developments
4.3 Grifols
4.3.1 Grifols Company Information
4.3.2 Grifols Business Overview
4.3.3 Grifols Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Grifols Colloids (Blood Plasma) Product Portfolio
4.3.5 Grifols Recent Developments
4.4 Octapharma
4.4.1 Octapharma Company Information
4.4.2 Octapharma Business Overview
4.4.3 Octapharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Octapharma Colloids (Blood Plasma) Product Portfolio
4.4.5 Octapharma Recent Developments
4.5 Kedrion
4.5.1 Kedrion Company Information
4.5.2 Kedrion Business Overview
4.5.3 Kedrion Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Kedrion Colloids (Blood Plasma) Product Portfolio
4.5.5 Kedrion Recent Developments
4.6 Shanghai Raas
4.6.1 Shanghai Raas Company Information
4.6.2 Shanghai Raas Business Overview
4.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Shanghai Raas Colloids (Blood Plasma) Product Portfolio
4.6.5 Shanghai Raas Recent Developments
4.7 CTBB
4.7.1 CTBB Company Information
4.7.2 CTBB Business Overview
4.7.3 CTBB Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.7.4 CTBB Colloids (Blood Plasma) Product Portfolio
4.7.5 CTBB Recent Developments
4.8 Hualan Bio
4.8.1 Hualan Bio Company Information
4.8.2 Hualan Bio Business Overview
4.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Hualan Bio Colloids (Blood Plasma) Product Portfolio
4.8.5 Hualan Bio Recent Developments
4.9 Rongsheng Pharmaceutical
4.9.1 Rongsheng Pharmaceutical Company Information
4.9.2 Rongsheng Pharmaceutical Business Overview
4.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio
4.9.5 Rongsheng Pharmaceutical Recent Developments
4.10 Boya Rongsheng
4.10.1 Boya Rongsheng Company Information
4.10.2 Boya Rongsheng Business Overview
4.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Boya Rongsheng Colloids (Blood Plasma) Product Portfolio
4.10.5 Boya Rongsheng Recent Developments
4.11 B. Braun Medical
4.11.1 B. Braun Medical Company Information
4.11.2 B. Braun Medical Business Overview
4.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.11.4 B. Braun Medical Colloids (Blood Plasma) Product Portfolio
4.11.5 B. Braun Medical Recent Developments
4.12 Fresenius Kabi
4.12.1 Fresenius Kabi Company Information
4.12.2 Fresenius Kabi Business Overview
4.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.12.4 Fresenius Kabi Colloids (Blood Plasma) Product Portfolio
4.12.5 Fresenius Kabi Recent Developments
4.13 HOSPIRA
4.13.1 HOSPIRA Company Information
4.13.2 HOSPIRA Business Overview
4.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.13.4 HOSPIRA Colloids (Blood Plasma) Product Portfolio
4.13.5 HOSPIRA Recent Developments
4.14 Axa parenterals
4.14.1 Axa parenterals Company Information
4.14.2 Axa parenterals Business Overview
4.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.14.4 Axa parenterals Colloids (Blood Plasma) Product Portfolio
4.14.5 Axa parenterals Recent Developments
4.15 Fresenius Kabi (China)
4.15.1 Fresenius Kabi (China) Company Information
4.15.2 Fresenius Kabi (China) Business Overview
4.15.3 Fresenius Kabi (China) Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.15.4 Fresenius Kabi (China) Colloids (Blood Plasma) Product Portfolio
4.15.5 Fresenius Kabi (China) Recent Developments
4.16 CR Double-Crane
4.16.1 CR Double-Crane Company Information
4.16.2 CR Double-Crane Business Overview
4.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.16.4 CR Double-Crane Colloids (Blood Plasma) Product Portfolio
4.16.5 CR Double-Crane Recent Developments
4.17 Kelun Group
4.17.1 Kelun Group Company Information
4.17.2 Kelun Group Business Overview
4.17.3 Kelun Group Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.17.4 Kelun Group Colloids (Blood Plasma) Product Portfolio
4.17.5 Kelun Group Recent Developments
4.18 Shandong Qidu Pharmaceutical
4.18.1 Shandong Qidu Pharmaceutical Company Information
4.18.2 Shandong Qidu Pharmaceutical Business Overview
4.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
4.18.5 Shandong Qidu Pharmaceutical Recent Developments
4.19 Shandong Hualu Pharmaceutical
4.19.1 Shandong Hualu Pharmaceutical Company Information
4.19.2 Shandong Hualu Pharmaceutical Business Overview
4.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
4.19.5 Shandong Hualu Pharmaceutical Recent Developments
4.20 Minsheng Pharma
4.20.1 Minsheng Pharma Company Information
4.20.2 Minsheng Pharma Business Overview
4.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.20.4 Minsheng Pharma Colloids (Blood Plasma) Product Portfolio
4.20.5 Minsheng Pharma Recent Developments
4.21 Kanglepharm
4.21.1 Kanglepharm Company Information
4.21.2 Kanglepharm Business Overview
4.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2021-2026)
4.21.4 Kanglepharm Colloids (Blood Plasma) Product Portfolio
4.21.5 Kanglepharm Recent Developments
5 Global Colloids (Blood Plasma) Market Scenario by Region
5.1 Global Colloids (Blood Plasma) Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Colloids (Blood Plasma) Sales by Region: 2021-2032
5.2.1 Global Colloids (Blood Plasma) Sales by Region: 2021-2026
5.2.2 Global Colloids (Blood Plasma) Sales by Region: 2027-2032
5.3 Global Colloids (Blood Plasma) Revenue by Region: 2021-2032
5.3.1 Global Colloids (Blood Plasma) Revenue by Region: 2021-2026
5.3.2 Global Colloids (Blood Plasma) Revenue by Region: 2027-2032
5.4 North America Colloids (Blood Plasma) Market Facts & Figures by Country
5.4.1 North America Colloids (Blood Plasma) Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Colloids (Blood Plasma) Sales by Country (2021-2032)
5.4.3 North America Colloids (Blood Plasma) Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Colloids (Blood Plasma) Market Facts & Figures by Country
5.5.1 Europe Colloids (Blood Plasma) Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Colloids (Blood Plasma) Sales by Country (2021-2032)
5.5.3 Europe Colloids (Blood Plasma) Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Colloids (Blood Plasma) Market Facts & Figures by Country
5.6.1 Asia Pacific Colloids (Blood Plasma) Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Colloids (Blood Plasma) Sales by Country (2021-2032)
5.6.3 Asia Pacific Colloids (Blood Plasma) Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Colloids (Blood Plasma) Market Facts & Figures by Country
5.7.1 South America Colloids (Blood Plasma) Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Colloids (Blood Plasma) Sales by Country (2021-2032)
5.7.3 South America Colloids (Blood Plasma) Revenue by Country (2021-2032)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Colloids (Blood Plasma) Market Facts & Figures by Country
5.8.1 Middle East and Africa Colloids (Blood Plasma) Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Colloids (Blood Plasma) Sales by Country (2021-2032)
5.8.3 Middle East and Africa Colloids (Blood Plasma) Revenue by Country (2021-2032)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Colloids (Blood Plasma) Sales by Type (2021-2032)
6.1.1 Global Colloids (Blood Plasma) Sales by Type (2021-2032) & (MT)
6.1.2 Global Colloids (Blood Plasma) Sales Market Share by Type (2021-2032)
6.2 Global Colloids (Blood Plasma) Revenue by Type (2021-2032)
6.2.1 Global Colloids (Blood Plasma) Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Colloids (Blood Plasma) Revenue Market Share by Type (2021-2032)
6.3 Global Colloids (Blood Plasma) Price by Type (2021-2032)
7 Segment by Application
7.1 Global Colloids (Blood Plasma) Sales by Application (2021-2032)
7.1.1 Global Colloids (Blood Plasma) Sales by Application (2021-2032) & (MT)
7.1.2 Global Colloids (Blood Plasma) Sales Market Share by Application (2021-2032)
7.2 Global Colloids (Blood Plasma) Revenue by Application (2021-2032)
7.2.1 Global Colloids (Blood Plasma) Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Colloids (Blood Plasma) Revenue Market Share by Application (2021-2032)
7.3 Global Colloids (Blood Plasma) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Colloids (Blood Plasma) Value Chain Analysis
8.1.1 Colloids (Blood Plasma) Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Colloids (Blood Plasma) Production Mode & Process
8.2 Colloids (Blood Plasma) Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Colloids (Blood Plasma) Distributors
8.2.3 Colloids (Blood Plasma) Customers
9 Global Colloids (Blood Plasma) Analyzing Market Dynamics
9.1 Colloids (Blood Plasma) Industry Trends
9.2 Colloids (Blood Plasma) Industry Drivers
9.3 Colloids (Blood Plasma) Industry Opportunities and Challenges
9.4 Colloids (Blood Plasma) Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Colloids (Blood Plasma) Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Colloids (Blood Plasma) Sales (MT) of Manufacturers (2021-2026)
Table 7. Global Colloids (Blood Plasma) Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Colloids (Blood Plasma) Revenue of Manufacturers (2021-2026)
Table 9. Global Colloids (Blood Plasma) Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Colloids (Blood Plasma) Average Price (USD/Kg) of Manufacturers (2021-2026)
Table 11. Global Colloids (Blood Plasma) Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Colloids (Blood Plasma), Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Colloids (Blood Plasma), Product Type & Application
Table 14. Global Colloids (Blood Plasma) Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Colloids (Blood Plasma) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. CSL Behring Company Information
Table 19. CSL Behring Business Overview
Table 20. CSL Behring Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 21. CSL Behring Colloids (Blood Plasma) Product Portfolio
Table 22. CSL Behring Recent Developments
Table 23. Baxter Company Information
Table 24. Baxter Business Overview
Table 25. Baxter Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 26. Baxter Colloids (Blood Plasma) Product Portfolio
Table 27. Baxter Recent Developments
Table 28. Grifols Company Information
Table 29. Grifols Business Overview
Table 30. Grifols Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 31. Grifols Colloids (Blood Plasma) Product Portfolio
Table 32. Grifols Recent Developments
Table 33. Octapharma Company Information
Table 34. Octapharma Business Overview
Table 35. Octapharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 36. Octapharma Colloids (Blood Plasma) Product Portfolio
Table 37. Octapharma Recent Developments
Table 38. Kedrion Company Information
Table 39. Kedrion Business Overview
Table 40. Kedrion Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 41. Kedrion Colloids (Blood Plasma) Product Portfolio
Table 42. Kedrion Recent Developments
Table 43. Shanghai Raas Company Information
Table 44. Shanghai Raas Business Overview
Table 45. Shanghai Raas Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 46. Shanghai Raas Colloids (Blood Plasma) Product Portfolio
Table 47. Shanghai Raas Recent Developments
Table 48. CTBB Company Information
Table 49. CTBB Business Overview
Table 50. CTBB Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 51. CTBB Colloids (Blood Plasma) Product Portfolio
Table 52. CTBB Recent Developments
Table 53. Hualan Bio Company Information
Table 54. Hualan Bio Business Overview
Table 55. Hualan Bio Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 56. Hualan Bio Colloids (Blood Plasma) Product Portfolio
Table 57. Hualan Bio Recent Developments
Table 58. Rongsheng Pharmaceutical Company Information
Table 59. Rongsheng Pharmaceutical Business Overview
Table 60. Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 61. Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio
Table 62. Rongsheng Pharmaceutical Recent Developments
Table 63. Boya Rongsheng Company Information
Table 64. Boya Rongsheng Business Overview
Table 65. Boya Rongsheng Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 66. Boya Rongsheng Colloids (Blood Plasma) Product Portfolio
Table 67. Boya Rongsheng Recent Developments
Table 68. B. Braun Medical Company Information
Table 69. B. Braun Medical Business Overview
Table 70. B. Braun Medical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 71. B. Braun Medical Colloids (Blood Plasma) Product Portfolio
Table 72. B. Braun Medical Recent Developments
Table 73. Fresenius Kabi Company Information
Table 74. Fresenius Kabi Business Overview
Table 75. Fresenius Kabi Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 76. Fresenius Kabi Colloids (Blood Plasma) Product Portfolio
Table 77. Fresenius Kabi Recent Developments
Table 78. HOSPIRA Company Information
Table 79. HOSPIRA Business Overview
Table 80. HOSPIRA Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 81. HOSPIRA Colloids (Blood Plasma) Product Portfolio
Table 82. HOSPIRA Recent Developments
Table 83. Axa parenterals Company Information
Table 84. Axa parenterals Business Overview
Table 85. Axa parenterals Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 86. Axa parenterals Colloids (Blood Plasma) Product Portfolio
Table 87. Axa parenterals Recent Developments
Table 88. Fresenius Kabi (China) Company Information
Table 89. Fresenius Kabi (China) Business Overview
Table 90. Fresenius Kabi (China) Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 91. Fresenius Kabi (China) Colloids (Blood Plasma) Product Portfolio
Table 92. Fresenius Kabi (China) Recent Developments
Table 93. CR Double-Crane Company Information
Table 94. CR Double-Crane Business Overview
Table 95. CR Double-Crane Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 96. CR Double-Crane Colloids (Blood Plasma) Product Portfolio
Table 97. CR Double-Crane Recent Developments
Table 98. Kelun Group Company Information
Table 99. Kelun Group Business Overview
Table 100. Kelun Group Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 101. Kelun Group Colloids (Blood Plasma) Product Portfolio
Table 102. Kelun Group Recent Developments
Table 103. Shandong Qidu Pharmaceutical Company Information
Table 104. Shandong Qidu Pharmaceutical Business Overview
Table 105. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 106. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
Table 107. Shandong Qidu Pharmaceutical Recent Developments
Table 108. Shandong Hualu Pharmaceutical Company Information
Table 109. Shandong Hualu Pharmaceutical Business Overview
Table 110. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 111. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
Table 112. Shandong Hualu Pharmaceutical Recent Developments
Table 113. Minsheng Pharma Company Information
Table 114. Minsheng Pharma Business Overview
Table 115. Minsheng Pharma Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 116. Minsheng Pharma Colloids (Blood Plasma) Product Portfolio
Table 117. Minsheng Pharma Recent Developments
Table 118. Kanglepharm Company Information
Table 119. Kanglepharm Business Overview
Table 120. Kanglepharm Colloids (Blood Plasma) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 121. Kanglepharm Colloids (Blood Plasma) Product Portfolio
Table 122. Kanglepharm Recent Developments
Table 123. Global Colloids (Blood Plasma) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 124. Global Colloids (Blood Plasma) Sales by Region (2021-2026) & (MT)
Table 125. Global Colloids (Blood Plasma) Sales Market Share by Region (2021-2026)
Table 126. Global Colloids (Blood Plasma) Sales by Region (2027-2032) & (MT)
Table 127. Global Colloids (Blood Plasma) Sales Market Share by Region (2027-2032)
Table 128. Global Colloids (Blood Plasma) Revenue by Region (2021-2026) & (US$ Million)
Table 129. Global Colloids (Blood Plasma) Revenue Market Share by Region (2021-2026)
Table 130. Global Colloids (Blood Plasma) Revenue by Region (2027-2032) & (US$ Million)
Table 131. Global Colloids (Blood Plasma) Revenue Market Share by Region (2027-2032)
Table 132. North America Colloids (Blood Plasma) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 133. North America Colloids (Blood Plasma) Sales by Country (2021-2026) & (MT)
Table 134. North America Colloids (Blood Plasma) Sales by Country (2027-2032) & (MT)
Table 135. North America Colloids (Blood Plasma) Revenue by Country (2021-2026) & (US$ Million)
Table 136. North America Colloids (Blood Plasma) Revenue by Country (2027-2032) & (US$ Million)
Table 137. Europe Colloids (Blood Plasma) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 138. Europe Colloids (Blood Plasma) Sales by Country (2021-2026) & (MT)
Table 139. Europe Colloids (Blood Plasma) Sales by Country (2027-2032) & (MT)
Table 140. Europe Colloids (Blood Plasma) Revenue by Country (2021-2026) & (US$ Million)
Table 141. Europe Colloids (Blood Plasma) Revenue by Country (2027-2032) & (US$ Million)
Table 142. Asia Pacific Colloids (Blood Plasma) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 143. Asia Pacific Colloids (Blood Plasma) Sales by Country (2021-2026) & (MT)
Table 144. Asia Pacific Colloids (Blood Plasma) Sales by Country (2027-2032) & (MT)
Table 145. Asia Pacific Colloids (Blood Plasma) Revenue by Country (2021-2026) & (US$ Million)
Table 146. Asia Pacific Colloids (Blood Plasma) Revenue by Country (2027-2032) & (US$ Million)
Table 147. South America Colloids (Blood Plasma) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 148. South America Colloids (Blood Plasma) Sales by Country (2021-2026) & (MT)
Table 149. South America Colloids (Blood Plasma) Sales by Country (2027-2032) & (MT)
Table 150. South America Colloids (Blood Plasma) Revenue by Country (2021-2026) & (US$ Million)
Table 151. South America Colloids (Blood Plasma) Revenue by Country (2027-2032) & (US$ Million)
Table 152. Middle East and Africa Colloids (Blood Plasma) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 153. Middle East and Africa Colloids (Blood Plasma) Sales by Country (2021-2026) & (MT)
Table 154. Middle East and Africa Colloids (Blood Plasma) Sales by Country (2027-2032) & (MT)
Table 155. Middle East and Africa Colloids (Blood Plasma) Revenue by Country (2021-2026) & (US$ Million)
Table 156. Middle East and Africa Colloids (Blood Plasma) Revenue by Country (2027-2032) & (US$ Million)
Table 157. Global Colloids (Blood Plasma) Sales by Type (2021-2026) & (MT)
Table 158. Global Colloids (Blood Plasma) Sales by Type (2027-2032) & (MT)
Table 159. Global Colloids (Blood Plasma) Sales Market Share by Type (2021-2026)
Table 160. Global Colloids (Blood Plasma) Sales Market Share by Type (2027-2032)
Table 161. Global Colloids (Blood Plasma) Revenue by Type (2021-2026) & (US$ Million)
Table 162. Global Colloids (Blood Plasma) Revenue by Type (2027-2032) & (US$ Million)
Table 163. Global Colloids (Blood Plasma) Revenue Market Share by Type (2021-2026)
Table 164. Global Colloids (Blood Plasma) Revenue Market Share by Type (2027-2032)
Table 165. Global Colloids (Blood Plasma) Price by Type (2021-2026) & (USD/Kg)
Table 166. Global Colloids (Blood Plasma) Price by Type (2027-2032) & (USD/Kg)
Table 167. Global Colloids (Blood Plasma) Sales by Application (2021-2026) & (MT)
Table 168. Global Colloids (Blood Plasma) Sales by Application (2027-2032) & (MT)
Table 169. Global Colloids (Blood Plasma) Sales Market Share by Application (2021-2026)
Table 170. Global Colloids (Blood Plasma) Sales Market Share by Application (2027-2032)
Table 171. Global Colloids (Blood Plasma) Revenue by Application (2021-2026) & (US$ Million)
Table 172. Global Colloids (Blood Plasma) Revenue by Application (2027-2032) & (US$ Million)
Table 173. Global Colloids (Blood Plasma) Revenue Market Share by Application (2021-2026)
Table 174. Global Colloids (Blood Plasma) Revenue Market Share by Application (2027-2032)
Table 175. Global Colloids (Blood Plasma) Price by Application (2021-2026) & (USD/Kg)
Table 176. Global Colloids (Blood Plasma) Price by Application (2027-2032) & (USD/Kg)
Table 177. Key Raw Materials
Table 178. Raw Materials Key Suppliers
Table 179. Colloids (Blood Plasma) Distributors List
Table 180. Colloids (Blood Plasma) Customers List
Table 181. Colloids (Blood Plasma) Industry Trends
Table 182. Colloids (Blood Plasma) Industry Drivers
Table 183. Colloids (Blood Plasma) Industry Restraints
Table 184. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Colloids (Blood Plasma) Product Image
Figure 5. Global Colloids (Blood Plasma) Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Colloids (Blood Plasma) Market Size (2021-2032) & (US$ Million)
Figure 7. Global Colloids (Blood Plasma) Sales (2021-2032) & (MT)
Figure 8. Global Colloids (Blood Plasma) Average Price (USD/Kg) & (2021-2032)
Figure 9. Natural Type Colloids (Blood Plasma) Product Image
Figure 10. Synthetic Type Colloids (Blood Plasma) Product Image
Figure 11. Extensive Burns Product Image
Figure 12. Massive Blood or Plasma Loss Product Image
Figure 13. Hypovolemic Shock Product Image
Figure 14. Others Product Image
Figure 15. Global Colloids (Blood Plasma) Revenue Share by Manufacturers in 2025
Figure 16. Global Manufacturers of Colloids (Blood Plasma), Manufacturing Sites & Headquarters
Figure 17. Global Top 5 and 10 Colloids (Blood Plasma) Players Market Share by Revenue in 2025
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 19. Global Colloids (Blood Plasma) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 20. Global Colloids (Blood Plasma) Sales by Region in 2025
Figure 21. Global Colloids (Blood Plasma) Revenue by Region in 2025
Figure 22. North America Colloids (Blood Plasma) Market Size by Country in 2025
Figure 23. North America Colloids (Blood Plasma) Sales Market Share by Country (2021-2032)
Figure 24. North America Colloids (Blood Plasma) Revenue Market Share by Country (2021-2032)
Figure 25. United States Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Canada Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Mexico Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 28. Europe Colloids (Blood Plasma) Market Size by Country in 2025
Figure 29. Europe Colloids (Blood Plasma) Sales Market Share by Country (2021-2032)
Figure 30. Europe Colloids (Blood Plasma) Revenue Market Share by Country (2021-2032)
Figure 31. Germany Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. France Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. U.K. Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Italy Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Russia Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Spain Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Netherlands Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Switzerland Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Sweden Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Poland Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Asia Pacific Colloids (Blood Plasma) Market Size by Country in 2025
Figure 42. Asia Pacific Colloids (Blood Plasma) Sales Market Share by Country (2021-2032)
Figure 43. Asia Pacific Colloids (Blood Plasma) Revenue Market Share by Country (2021-2032)
Figure 44. China Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. Japan Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. South Korea Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. India Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Australia Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Taiwan Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Southeast Asia Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Southeast Asia Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. South America Colloids (Blood Plasma) Market Size by Country in 2025
Figure 53. South America Colloids (Blood Plasma) Sales Market Share by Country (2021-2032)
Figure 54. South America Colloids (Blood Plasma) Revenue Market Share by Country (2021-2032)
Figure 55. Brazil Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Argentina Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Chile Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Middle East and Africa Colloids (Blood Plasma) Market Size by Country in 2025
Figure 59. Middle East and Africa Colloids (Blood Plasma) Sales Market Share by Country (2021-2032)
Figure 60. Middle East and Africa Colloids (Blood Plasma) Revenue Market Share by Country (2021-2032)
Figure 61. Egypt Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. South Africa Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. Israel Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. Türkiye Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. GCC Countries Colloids (Blood Plasma) Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. Global Colloids (Blood Plasma) Sales Market Share by Type (2021-2032)
Figure 67. Global Colloids (Blood Plasma) Revenue Market Share by Type (2021-2032)
Figure 68. Global Colloids (Blood Plasma) Price (USD/Kg) by Type (2021-2032)
Figure 69. Global Colloids (Blood Plasma) Sales Market Share by Application (2021-2032)
Figure 70. Global Colloids (Blood Plasma) Revenue Market Share by Application (2021-2032)
Figure 71. Global Colloids (Blood Plasma) Price (USD/Kg) by Application (2021-2032)
Figure 72. Colloids (Blood Plasma) Value Chain
Figure 73. Colloids (Blood Plasma) Production Mode & Process
Figure 74. Direct Comparison with Distribution Share
Figure 75. Distributors Profiles
Figure 76. Colloids (Blood Plasma) Industry Opportunities and Challenges
提及公司
CSL BehringBaxterGrifolsOctapharmaKedrionShanghai RaasCTBBHualan BioRongsheng PharmaceuticalBoya RongshengB. Braun MedicalFresenius KabiHOSPIRAAxa parenteralsFresenius Kabi (China)CR Double-CraneKelun GroupShandong Qidu PharmaceuticalShandong Hualu PharmaceuticalMinsheng PharmaKanglepharm
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們